研究发现，长期使用某些孕激素药物会增加患颅内脑膜瘤的风险。 Study finds prolonged use of certain progestogen hormone drugs increases risk of intracranial meningiomas.

一项新的研究警告说，长期使用某些孕激素药物，如甲孕酮和醋酸甲羟孕酮注射液，会增加患颅内脑膜瘤（一种脑肿瘤）的风险。 A new study warns that prolonged use of certain progestogen hormone drugs, like medrogestone and medroxyprogesterone acetate injection, increases the risk of developing intracranial meningiomas, a type of brain tumor. 这是第一项评估全球数百万女性使用孕激素相关风险的研究。 This is the first study to assess the risk associated with progestogens used by millions of women worldwide. 这项发表在《英国医学杂志》上的研究调查了孕激素药物与脑膜瘤风险之间的关联，发现某些类型的孕激素剂量过高与脑膜瘤有关；然而，在观察性研究中无法确定因果关系。 The research, published in The BMJ, investigated the association of progestogen medications and risk of meningioma, finding an association for high doses of certain types of progestogens; however, causality cannot be determined in an observational study.